Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Peptic Ulcer

  Free Subscription


2 Am J Gastroenterol
2 BMC Gastroenterol
2 Dig Dis Sci
1 Endoscopy
1 Eur J Pharmacol
3 Gastroenterology
8 Helicobacter
2 J Ethnopharmacol
1 J Gastroenterol
1 J Gastroenterol Hepatol
1 Surg Endosc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. BUJANDA L, Nyssen OP, Ramos J, Bordin DS, et al
    Effectiveness of Helicobacter pylori treatments according to antibiotic resistance.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002600.
    PubMed         Abstract available

  2. YAN TL, Wang JH, He XJ, Zhu YB, et al
    Ten-day vonoprazan-amoxicillin dual therapy versus standard fourteen-day Bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002592.
    PubMed         Abstract available

    BMC Gastroenterol

  3. ZHU Y, Yang W, Zhang Y, Ye L, et al
    The value of endoscopically-placed metal clips for transcatheter arterial embolization in the treatment of recurrent acute non-variceal upper gastrointestinal bleeding.
    BMC Gastroenterol. 2023;23:396.
    PubMed         Abstract available

  4. LIU D, Ren L, Zhong D, Zhang W, et al
    Association of serum vitamin D levels on Helicobacter pylori infection: a retrospective study with real-world data.
    BMC Gastroenterol. 2023;23:391.
    PubMed         Abstract available

    Dig Dis Sci

  5. WONG ZY, Koh JH, Muthiah M, Koh B, et al
    Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
    PubMed         Abstract available

  6. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    PubMed         Abstract available


  7. BURLEN J, Manudhane A, Roberts L, Cecilia Amaral A, et al
    Single-session endoscopic ultrasound-directed transgastric endoscopy for treatment of upper gastrointestinal bleeding after Roux-en-Y gastric bypass.
    Endoscopy. 2023;55.

    Eur J Pharmacol

  8. LOPES ALF, Araujo AKDS, Chaves LS, Pacheco G, et al
    Protective effect of alpha-ketoglutarate against water-immersion restraint stress-induced gastric mucosal damage in mice.
    Eur J Pharmacol. 2023;960:176118.
    PubMed         Abstract available


  9. CHEN YY, Chang HM, Chen CH
    A Rare Cause of Duodenal ulcer.
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05225.

  10. MURUAGA EJ, Jones NL
    Helicobacter pylori genetic variations: A driver of gastric cancer progression?
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05226.

  11. FORD AC, Graham DY
    Toward quantification of H. pylori-associated gastric cancer risk: Further evidence supporting development of population-based strategies for H. pylori eradication.
    Gastroenterology. 2023 Nov 2:S0016-5085(23)05203.


  12. LEE CT, Wu CT, Chang WL, Yang EH, et al
    The nonadherence and risk factors of eradication failure by sequential therapy as first-line anti-Helicobacter pylori treatment in real-world clinical practice.
    Helicobacter. 2023 Nov 10:e13033. doi: 10.1111/hel.13033.
    PubMed         Abstract available

  13. FANI T, Ioannis TG
    Letter to the Editor regarding the article: "Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy".
    Helicobacter. 2023 Nov 13:e13035. doi: 10.1111/hel.13035.

  14. YUNLE K, Tong W, Jiyang L, Guojun W, et al
    Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants-A review.
    Helicobacter. 2023 Nov 16:e13034. doi: 10.1111/hel.13034.
    PubMed         Abstract available

  15. VERNON-ROBERTS A, Premaratne M, Wright R, Keenan JI, et al
    Profile of Helicobacter pylori infections among children in the South Island of New Zealand (2010-2021).
    Helicobacter. 2023 Nov 20:e13037. doi: 10.1111/hel.13037.
    PubMed         Abstract available

  16. ZHOU BG, Jiang X, Ding YB, She Q, et al
    Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Helicobacter. 2023 Nov 20:e13040. doi: 10.1111/hel.13040.
    PubMed         Abstract available

  17. XU W, Yang B, Lin L, Lin Q, et al
    Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023.
    Helicobacter. 2023 Nov 20:e13038. doi: 10.1111/hel.13038.
    PubMed         Abstract available

  18. LIM NR, Kim J, Chung WC
    Recurrence of Helicobacter pylori following successful eradication and clinical outcomes in Korean patients.
    Helicobacter. 2023 Nov 20:e13036. doi: 10.1111/hel.13036.
    PubMed         Abstract available

  19. MELO J, Cavadas B, Pereira L, Figueiredo C, et al
    Transcriptomic remodeling of gastric cells by Helicobacter pylori outer membrane vesicles.
    Helicobacter. 2023 Nov 23:e13031. doi: 10.1111/hel.13031.
    PubMed         Abstract available

    J Ethnopharmacol

  20. ALI NB, Abdelhamid Ibrahim SS, Alsherbiny MA, Sheta E, et al
    Gastroprotective potential of red onion (Allium cepa L.) peel in ethanol-induced gastric injury in rats: Involvement of Nrf2/HO-1 and HMGB-1/NF-kappaB trajectories.
    J Ethnopharmacol. 2024;319.
    PubMed         Abstract available

  21. OU L, Liu HR, Shi XY, Peng C, et al
    Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway.
    J Ethnopharmacol. 2023 Nov 17:117428. doi: 10.1016/j.jep.2023.117428.
    PubMed         Abstract available

    J Gastroenterol

  22. KAWAGUCHI T, Okamoto K, Fujimoto S, Bando M, et al
    Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway.
    J Gastroenterol. 2023 Nov 22. doi: 10.1007/s00535-023-02052.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  23. SUN Y, Zhang A, Zuo M, Chen J, et al
    A pharmacovigilance study of association between proton-pump inhibitors and rhabdomyolysis event based on FAERS database.
    J Gastroenterol Hepatol. 2023 Nov 14. doi: 10.1111/jgh.16411.
    PubMed         Abstract available

    Surg Endosc

  24. BIERMANN M, Hersh M, Kline M, Fowler H, et al
    Functional lumen imaging probe topography identifies patients with normal acid exposure and esophageal hypervigilance amongst proton-pump inhibitor non-responders.
    Surg Endosc. 2023 Nov 22. doi: 10.1007/s00464-023-10556.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.